Nonalcoholic fatty liver disease (NAFLD) is a multisystemic clinical condition that presents
with a wide spectrum of extrahepatic manifestations, such as obesity, type 2 diabetes …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide, with a broad spectrum ranging from simple steatosis to advanced stage of …

Background Metabolic dysfunction-associated fatty liver disease [MAFLD, formerly known as
nonalcoholic fatty liver disease (NAFLD)] is one of the most important causes of liver disease …

Nonalcoholic fatty liver disease (NAFLD) is the commonest cause of chronic liver disease
worldwide. It is closely related to obesity, insulin resistance (IR) and dyslipidemia so much …

Metabolism-associated fatty liver disease (MAFLD) is a multifaceted disease that involves
complex interactions between various organs, including the gut and heart. It is defined by …

Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver
disease worldwide, with an estimated global prevalence of 32.4%. 1 Although a Division of …

Non-alcoholic fatty liver disease (NAFLD) represents the hepatic expression of the metabolic
syndrome and is the most prevalent liver disease. NAFLD is associated with liver-related …

Dyslipidemia and cardiovascular complications are comorbidities of nonalcoholic fatty liver
disease (NAFLD), which ranges from simple steatosis to nonalcoholic steatohepatitis …

Non-alcoholic fatty liver disease (NAFLD) is a heterogeneous condition with a wide
spectrum of clinical presentations and natural history and disease severity. There is also …

Non-alcoholic fatty liver disease (NAFLD) is characterized by the excessive and detrimental
accumulation of liver fat as a result of high-caloric intake and/or cellular and molecular …